Citation: Kj. Kao, Mechanisms and new approaches for the allogeneic blood transfusion-inducedimmunomodulatory effects, TR MED REV, 14(1), 2000, pp. 12-22
Citation: Ec. Vamvakas et Ma. Blajchmn, Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion, TR MED REV, 14(1), 2000, pp. 23-33
Citation: Lc. Richardson et Bl. Evatt, Risk of hepatitis A virus infection in persons with hemophilia receiving plasma-derived products, TR MED REV, 14(1), 2000, pp. 64-73
Citation: Cf. Hogman et Ht. Meryman, Storage parameters affecting red blood cell survival and function after transfusion, TR MED REV, 13(4), 1999, pp. 275-296
Citation: Wj. Judd, Elution - Dissociation of antibody from red blood cells: Theoretical and practical considerations, TR MED REV, 13(4), 1999, pp. 297-310
Citation: La. Chambers et Jh. Herman, Considerations in the selection of a platelet component: Apheresis versus whole blood-derived, TR MED REV, 13(4), 1999, pp. 311-322
Citation: Ia. Shulman, Intervention strategies to reduce the risk of transfusion-transmitted Trypanosoma cruzi infection in the United States, TR MED REV, 13(3), 1999, pp. 227-234
Citation: Mf. Murphy, New variant Creutzfeldt-Jakob Disease (nvCJD): The risk of transmission byblood transfusion and the potential benefit of leukocyte-reduction of blood components, TR MED REV, 13(2), 1999, pp. 75-83
Citation: Vmj. Novotny et al., The reduction of HLA class I expression on platelets: A potential approachin the management of HLA-alloimmunized refractory patients, TR MED REV, 13(2), 1999, pp. 95-105